Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

Journal of the National Cancer Institute

Volumn 80, Issue 20, 1988, Pages 1605-1611

  Aboud pirak, Esther ^a   Hurwitz, Esther ^a   Pirak, Michael E ^b   Bellot, Francoise ^c   Schlessinger, Joseph ^a,c   Sela, Michael ^d  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b Life Science Research Israel   (Israel)

^c Rorer Biotechnology Inc ^*  (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMAL; ANTIBODIES, MONOCLONAL; IMMUNOGLOBULINS, FAB; KB CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS;

EID: 0024261027     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/80.20.1605     Document Type: Article

References (63)

1. DOUGHERTY TJ. Photosensitizes therapy and detection of malignant tumors. Photochem Photobiol 1987;45:879-889.
2. WEISHAUPT KR, GOMER CJ, DOUGHERTY TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;6:2326-2329.
3. GROSSWEWER LL Membrane photosensitization by hematoporphyrin and hematoporphyrin derivative. In: Doiron DR, Gomer CJ, eds. Porphyrin localization and treatment of tumors. New York: Liss, 1984:391-404.
4. BERNS MW, DAHLMAN A, JOHNSON F, et al. In vitro cellular effects of hematoporphyrin derivative. Cancer Res 1982;42:2325-2329.
5. TORINUKI L, MIORA T, SEUI M. Lysosome destruction and lipoperoxide formation due to active oxygen generated from hematoporphyrin on UV radiation. Br J Dermatol 1980; 102:17-27.
6. FOOTE CS. Photosensitized oxidation and singlet oxygen: consequences in biological systems. In: Pryor WA, ed. Free radicals in biology, vol II. New York: Academic Press, 1976:85-124.
7. DOUGHERTY TJ. Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981;77:122-124.
8. RETTENMAIER MA, BERMAN ML, DISAIA PJ, et al. Gynecologic uses of photoradiation therapy. In: Doiron DR, Gomer CJ, eds. Advances in experimental medicine and biology, vol 170. New York: Liss, 1984:767-775.
9. DOUGHERTY TJ. Photodynamic therapy (PDT) of malignant tumors. CRC Crit Rev Oncol Hematol 1984;2:83-116.
10. HAYATA Y, KATO H. Applications of laser phototherapy in the diagnosis and treatment of lung cancer. Jpn Ann Thoracic Surg 1983;3:203-210.
11. BENSON RC, FARROW GM, KJNSEY JH, et al. Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc 1982;7:548-555.
12. BRUCE BA. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanoma. Lasers Surg Med 1984;4:59-64.
13. DOUGHERTY TJ, LAWRENCE G, KAUFMAN GH, et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62:231-236.
14. WILE AG, DAHLMAN A, BURNS RG, et al. Laser photoradiation therapy of cancer following hematoporphyrin sensitization. Lasers Surg Med 1982;2:163-168.
15. NELSON JS, LLAW L-H, BERNS MW. Mechanism of tumor destruction in photodynamic therapy. Photochem Photobiol 1987;46:829-836.
16. NELSON JS, WRIGHT WH, BERNS MW. Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer enhanced digital video fluorescence microscopy. Cancer Res 1985;45:5781-5786.
17. ROBERTS WG, SHIAU F-Y, NELSON JS, et al. In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy. J Natl Cancer Inst 1988;80:330-336.
18. NELSON JS, ROBERTS WG, BERNS MW. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Cancer Res 1987;47:4681-4685.
19. SELMAN SH, KREIMER-BIRNBAUM M, KLAUNIG JE, et al. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative. Cancer Res I984;44:1924-1927.
20. STAR WM, MARUNISSEN HPA, VAN DEN BERG-BLOK AE, et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 1986;46:2532-2540.
21. HENDERSON BW, WALDOW SM, MANG TS, et al. Tumor destruction and kinetics by tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45:572-576.
22. JAIN RK. Transport of macromolecules in tumor microcirculation. Biotechnol Res 1985; 1:81-84.
23. JAIN RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-3051.
24. COMPER WD, LAURENT TC. Physiological function of connective tissue polysaccharides. Physiol Rev 1978;8:255-315.
25. LAURENT TC. Structure, function and turnover of the extracellular matrix. Adv Microcirc 1987;13:15-34.
26. GULUNO PM, GRANTHAM FH. The influence of the host and the neoplastic cell population on the collagen content of a tumor mass. Cancer Res 1963;3:648-653.
27. MUSSER DA, WAGNER JM, DATTA-GUPTA N. The interaction of tumor localizing porphyrins with collagen and elastin. Res Commun Chem Pathol Pharmacol 1982;36:251-259.
28. UBERMANN TA, RAZON N, BARTAL AD, et aL Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 1984;44:753-760.
29. OZAWA S, VUDA M, ANDO N, et aL High incidence of EGF receptor hyperproduction in esophageal squamous cell carcinomas. Int J Cancer 1987;39:333-337.
30. GuaucK WJ, MARSDEN JJ, WHITTLE N, et aL Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res 1986;46:285-292.
31. KAMATA N, CHIDA K, RDOMARU K, et aL Growth inhibitory effects of epidermal growth factor and overexpression of its receptor on human squamous cell carcinoma in culture. Cancer Res 1986;46:1648-1653.
32. COWLEY G, SMITH JA, GUSTERSON B, et aL The amount of EGF receptor is elevated in squamous cell carcinomas. In; Levine A, Vande Woude G, Topp W, et al, eds. Cancer cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1984;5-10.
33. YAMAMOTO T, KAMATA N, KAWANO H, et aL High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 1986;46:414-416.
34. OZANNE B, SHUM A, RICHARDS CS, et al. Evidence for an increase of EGF receptors in epidermoid malignancies. In: Faramisco J, Ozanne B, Stiles C, eds. Cancer cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1985:41-49.
35. HEADER M, ROTSCH M, BEPLER G, et al. Epidermal growth factor expression inhuman cancer cell lines. Cancer Res 1988;48:1132-1136.
36. NEAL DE, MARSH C, BENETT MK, et al. Epidermal growth factor receptor in human bladder cancer comparison of invasive and superficial tumors. Lancet 1985;1:366-368.
37. SAINSBURY JRC, FARNDON JR. SHERBET GV, et aL Epidermal growth factor receptors and estrogen receptors in human breast cancer. Lancet 1985; 1:364-366.
38. SAINSBURY JRC, MALCOLM AJ, APPLETON DR, et al. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985;8:1225-1228.
39. SAINSBURY JRC, FARNDON JR, NEEDHAM GK, et aL Epidermal-growthfactor receptor status as predictor of early recurrence and death from breast cancer. Lancet 1987;1:1398-1400.
40. SAOTON JB, CRONIN MT, MACLEOD CL, et aL Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res 1986;46:4701-4705.
41. CARPENTER G. Epidermal growth factor. Annu Rev Biochem 1979;48:193-215.
42. PATHAK MA, MATRISIAN LM, MAGUN BE, et aL Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. Int J Cancer 1982;30:745-750.
43. SINGLETARY SE, BAKER FL, SprrzER G, et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 1987;47:403-406.
44. SCHONBRUNN A, KRASNOFF M, WESTENDORF JM, et al. Epidermal growthfactor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J Cell Biol 1985;85:786-797.
45. GILL GN, LAZAR CS. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 1981;93:305-307.
46. BARNES DW. Epidermal growth factoT inhibits growth of A431 human epidermoid carcinoma in serum free cell culture. J Cell Biol 1982;93: 1-4.
47. SCHLESSINGER J. Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 1986;103:2067-2072.
48. LAEMMLI UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277;680-685.
49. HUNTER MW, GREENWOOD F. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962;194:495-496.
50. MASUI H, KAWAMOTO T, SATO JD, et aL Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 1984;44:1002-1007.
51. MASUI H, MOROYAMA T, MENDELSOHN J. Mechanism of anti-tumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res 1986, 46:5592-5598.
52. RODECK U, HERLYN M, HERLYN D, et al. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor immunologically mediated and effector cell-independent effects. Cancer Res 1987;47:3692-3696.
53. KAWAMOTO T, SATO DJ, LE A, et al. Growth stimulation of A431 cells by epidermal growth factor identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 1983;80:1337-1341.
54. HuRwrrz E, BUROWSKI D, KASHI R, et al. A synergistic effect between anti-idiotype antibodies and anti-neoplastic drugs in the therapy of a raurine B-cell tumor. Int J Cancer 1986;37:739-745.
55. WARD BG, WALLACE K, SHEPHERD JH, et al. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 1987;47:2662-2667.
56. RIPAMONTI M, CANEVARI S, MENARD S, et aL Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model. Cancer Immunol Immunother 1987;24: 13-18.
57. KYRIAHS AP, DIPERSIO L, MICHAEL GJ, et al. Growth patterns and metastatic behavior of human tumors growing in athymic mice. Cancer Res 1978;38:3186-3190.
58. VOLLMERS HP, IMHOF BA, WIELAND L et al. Monoclonal antibodies NORM-1 and NORM-2 induce monoclonal normal behavior of tumor cells in vitro and reduce tumor growth in vivo. Cell 1985;40:347-557.
59. EISENTHAL A, LAFRENIERE R, LEFOR AT, et al. Effect of anti-B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases. Cancer Res 1987;47:2771-2776.
60. BUCHEGGER F, HASKELL CM, SCHREYER M, et aL Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med 1983;158:413-427.
61. SCHEINBERO DA, STRAND M. Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice. Cancer Res 1983;43:265-272.
62. 2. J Nucl Med 1983;24:316- 325.
63. BROWN BA, COMEAU RD, JONES PL, et al. Phannacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either I23I or '"In. Cancer Res 1982;47:1149-1154.